Vulvar Lichen Sclerosus: Current Perspectives

被引:92
作者
Krapf, Jill M. [1 ,2 ]
Mitchell, Leia [2 ]
Holton, Michelle A. [3 ]
Goldstein, Andrew T. [1 ,2 ]
机构
[1] George Washington Univ, Washington, DC USA
[2] Ctr Vulvovaginal Disorders, 3 Washington Circle NW,Suite 205, Washington, DC 20037 USA
[3] Baystate Med Ctr, Dept Emergency Med, Springfield, MA USA
关键词
lichen sclerosus; clitoral phimosis; vulvar granuloma fissuratum; corticosteroids; fractional CO2 laser; lysis of vulvar adhesions; PLATELET-RICH PLASMA; NONNEOPLASTIC EPITHELIAL DISORDERS; EXTRACELLULAR-MATRIX PROTEIN-1; FOCUSED ULTRASOUND TREATMENT; LONG-TERM MANAGEMENT; CLOBETASOL PROPIONATE; DERMATOLOGISTS GUIDELINES; PHOTODYNAMIC THERAPY; BRITISH ASSOCIATION; TOPICAL APPLICATION;
D O I
10.2147/IJWH.S191200
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Vulvar lichen sclerosus (LS) is a chronic, inflammatory dermatosis that may lead to scarring of the vulva and sexual dysfunction. LS affects women of all ages and often goes unrecognized and underreported. Uncertainty continues to exist around its pathogenesis, histologic diagnosis, and treatment. However, there have been great advances in our understanding of autoimmunogenic targets in disease formation and progression. In addition, there has been recent investigation of potential non-steroid-based treatments, including plateletrich plasma therapy and energy-based modalities such as the fractional CO2 laser, photodynamic therapy, and high intensity focused ultrasound. Refinement of surgical techniques for restoring vulvar anatomy and treating clitoral phimosis, introital stenosis, and vulvar granuloma fissuratum is leading to improved patient outcomes. This review summarizes current perspectives on the pathogenesis, symptomatology, diagnosis, and treatment for vulvar lichen sclerosus.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 82 条
[1]   Updates in lichen sclerosis: British Association of Dermatologists guidelines for the management of lichen sclerosus 2018 [J].
Akel, R. ;
Fuller, C. .
BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (04) :823-824
[2]  
Andreassi M, 2013, EXPERT REV DERM, V8, P443, DOI [10.1586/17469872.2013.835923, DOI 10.1586/17469872.2013.835923]
[3]  
[Anonymous], 1988, BR J DERMATOL
[4]   Topical testosterone versus clobetasol for vulvar lichen sclerosus [J].
Ayhan, A. ;
Guven, S. ;
Guven, E. S. Guvendag ;
Sakinci, M. ;
Gultekin, M. ;
Kucukali, T. .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2007, 96 (02) :117-121
[5]   Fractional CO2 Laser Treatment for Vaginal Atrophy and Vulvar Lichen Sclerosus [J].
Baggish, Michael S. .
JOURNAL OF GYNECOLOGIC SURGERY, 2016, 32 (06) :309-317
[6]   Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma [J].
Bleeker, Maaike C. G. ;
Visser, Pascal J. ;
Overbeek, Lucy I. H. ;
van Beurden, Marc ;
Berkhof, Johannes .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (08) :1224-1230
[7]   Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus [J].
Bornstein, J ;
Heifetz, S ;
Kellner, Y ;
Stolar, Z ;
Abramovici, H .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (01) :80-84
[8]   The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) Terminology of Vulvar Squamous Intraepithelial Lesions [J].
Bornstein, Jacob ;
Bogliatto, Fabrizio ;
Haefner, Hope K. ;
Stockdale, Colleen K. ;
Preti, Mario ;
Bohl, Tanja G. ;
Reutter, Jason .
OBSTETRICS AND GYNECOLOGY, 2016, 127 (02) :264-268
[9]   Long-term management of vulval lichen sclerosus in adult women [J].
Bradford, J. ;
Fischer, G. .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2010, 50 (02) :148-152
[10]   Influence of treatments on prognosis for vulvar lichen sclerosus: Facts and controversies [J].
Brodrick, Brooks ;
Belkin, Zoe R. ;
Goldstein, Andrew T. .
CLINICS IN DERMATOLOGY, 2013, 31 (06) :780-786